<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02486549</url>
  </required_header>
  <id_info>
    <org_study_id>artroscopy</org_study_id>
    <nct_id>NCT02486549</nct_id>
  </id_info>
  <brief_title>Supraclavicular Versus Interscalene Block for Shoulder Surgery</brief_title>
  <official_title>A Prospective Randomized Comparison of Ultrasound-guided Supraclavicular and Interscalene Block in Patients Undergoing Arthroscopic Shoulder Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tokat Gaziosmanpasa University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tokat Gaziosmanpasa University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the supraclavicular block to interscalene block in
      patients undergoing arthroscopic shoulder surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the efficacy of the supraclavicular block in comparison
      with interscalene block on postoperative pain, quality of recovery and side effects in
      patients undergoing arthroscopic shoulder surgery under general anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Pain</measure>
    <time_frame>up to postoperative 24 hours</time_frame>
    <description>The visual analog scale will be used for assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery</measure>
    <time_frame>in the postoperative 24 hours</time_frame>
    <description>The Quality of Recovery-40 (QR40) questionnaire will be used for assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor block</measure>
    <time_frame>up to postoperative 24 hours</time_frame>
    <description>The muscle force will be evaluated with scale 0 to 3( 0:normal muscle force, 1: reduced muscle force, 2: impaired mobility 3: paralysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory block</measure>
    <time_frame>up to postoperative 24 hours</time_frame>
    <description>The sensorial block will be assessed by pinprick test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>up to postoperative 24 hours</time_frame>
    <description>The number of patients with adverse events will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesics requirement time</measure>
    <time_frame>up to postoperative 24 hours</time_frame>
    <description>the first intravenous analgesic requirement time will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood pressure changes</measure>
    <time_frame>at time of surgery</time_frame>
    <description>The blood pressure will be measured non invasively and the systolic blood pressure lower than 90 mmHg or decrease more than 20% of baseline will be accepted as a hypotension.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate changes</measure>
    <time_frame>at time of surgery</time_frame>
    <description>The heart rate will be assessed via electrocardiographic monitoring and recorded as beat/minute.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Supraclavicular Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound guided supraclavicular block with 20 ml of 0.25% bupivacaine will be performed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interscalene block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided inter scalene block with 20ml of 0.25% bupivacaine will be performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Supraclavicular Block</intervention_name>
    <description>Under ultrasound guidance an insulated needle is advanced with in- plane technique into the brachial plexus sheath and 20ml 0.25% bupivacaine will be administered</description>
    <arm_group_label>Supraclavicular Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Interscalene Block</intervention_name>
    <description>Under ultrasound guidance an insulated needle will be placed through the middle scalene muscle,into the interscalene groove with in-plane technique and 20ml 0.25%bupivacaine will be administered into the brachial plexus</description>
    <arm_group_label>Interscalene block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>20ml 0.25% bupivacaine will be injected for brachial plexus block</description>
    <arm_group_label>Supraclavicular Block</arm_group_label>
    <arm_group_label>Interscalene block</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>The Ultrasound will be used for brachial plexus visualization</description>
    <arm_group_label>Supraclavicular Block</arm_group_label>
    <arm_group_label>Interscalene block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing shoulder surgery in American Society of Anesthesiologists physical
             status I-II

        Exclusion Criteria:

          -  with a known allergy to study medications,

          -  chronic opioid use,

          -  ipsilateral upper limb neurological deficits,

          -  severe respiratory disease,

          -  coagulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tugba Karamanaraman, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gaziosmanpasa University Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gaziosmanpasa University Medical School</name>
      <address>
        <city>Tokat</city>
        <zip>60100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2015</study_first_submitted>
  <study_first_submitted_qc>June 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2015</study_first_posted>
  <last_update_submitted>February 20, 2017</last_update_submitted>
  <last_update_submitted_qc>February 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tokat Gaziosmanpasa University</investigator_affiliation>
    <investigator_full_name>TuÄŸba Karaman</investigator_full_name>
    <investigator_title>Assistant Professor, M.D.</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Anesthesia Recovery Period</keyword>
  <keyword>Brachial Plexus</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

